MyFinsight
Home
Blog
About
Foreign currency
exchange translation...
$538K
(-97.17%↓ Y/Y)
Total comprehensive
loss
-$38,585K
(-33.29%↓ Y/Y)
Total other
comprehensive income (loss),...
$526K
(-97.23%↓ Y/Y)
Unrealized holding
(losses) gains on...
-$12K
(45.45%↑ Y/Y)
Net loss
-$39,111K
(18.38%↑ Y/Y)
Interest expense, net
-$2,674K
(60.84%↑ Y/Y)
Interest income
$1,877K
(-64.14%↓ Y/Y)
Foreign exchange gains
(losses), net
$460K
(-69.31%↓ Y/Y)
Other income, net
$181K
(34.07%↑ Y/Y)
Net loss before
income tax
-$38,646K
(18.67%↑ Y/Y)
Income tax expense
$465K
(17.13%↑ Y/Y)
Total other income
(expenses), net
$5,192K
(-62.09%↓ Y/Y)
Product
$45,672K
(118.29%↑ Y/Y)
License
$17K
Loss from operations
-$43,838K
(28.39%↑ Y/Y)
Total revenue, net
$45,689K
(118.37%↑ Y/Y)
Selling, general and
administrative expenses
$41,161K
(36.00%↑ Y/Y)
Research and development
expenses, net
$27,898K
(1.71%↑ Y/Y)
Cost of sales
$20,468K
(-16.27%↓ Y/Y)
Back
Back
Income Statement
Autolus Therapeutics plc (AUTL)
Autolus Therapeutics plc (AUTL)
source: myfinsight.com